Location: Home
  • search
  • go
  • Relate News
  • 8/23/2021Sino Biological Raises $772 Million in Shenzhen ChiNext IPO
  • 8/23/2021Antengene Approved fpr Phase II Study of Selinexor for Myelofibrosis i...
  • 8/23/2021BeiGene Announces Acceptance of a sBLA in China for Tislelizumab in Na...
  • 8/23/2021Roche and KeChow Partner to Commercialize Zelboraf (vemurafenib) in Ch...
  • 8/23/2021Lonza Expands Guangzhou Manufacturing Facility with a Fill-finish Line
  • 8/23/2021China Passes New Data Privacy and Security Laws
  • 8/23/2021BioDuro-Sundia Acquires US-based Phase III/Commercial Drug Product Man...
  • 8/22/2021Abogen Raises $700M in Series C Financing for mRNA Trials
  • 8/20/2021Novartis Receives Approval for Lucentis and Launches Galvus in China
  • 8/20/2021Recent Executive Moves
  • 8/19/2021Draft Plan for National Level VBP of Insulin Products under Comment Se...
  • 8/19/2021Adagene Announces the Third Clinical Trial Collaboration with Merck to...
  • 8/18/2021Innoforce Opens Cell and Gene Therapy Facility in Hangzhou
  • 8/18/2021BeiGene and EUSA Pharma Announce NMPA Approval of QARZIBA (Dinutuximab...
  • 8/18/2021HiberCell Takes Over Gentility Science, Formerly Known as WuxiNextcode...
  • 8/18/2021Novartis Secures New Chinese Approval for Cosentyx (Secukinumab) in Pe...
  • 8/18/2021NMPA Issues the List of Reference Formulations for GQCE Studies (44th ...
  • 8/18/2021CDE Solicits Comments on the Technical Guidance for Clinical Trial Pro...
  • 8/18/2021CDE Solicits Comments on the Technical Guidance for Clinical Trials of...
  • 8/18/2021CDE Solicits Comments on the Technical Guidance for Clinical Trials of...
  • 8/18/2021CDE Solicits Comments on the Technical Guidance for Adverse Drug React...
  • 8/18/2021Arthrosi Establishes JV in China to Accelerate Development of Innovati...
  • 8/18/2021Junshi and Coherus Announce U.S. FDA Breakthrough Therapy Designation ...
  • 8/18/2021China's New Biosecurity Law Gives Limited Insight into Government Prio...
  • 8/17/2021CDE Publicizes the List of Reference Formulations for GQCE Studies (48...
  • 8/17/2021Amgen Secures Chinese Approval of Its Psoriasis Drug Otezla (Apremilas...
  • 8/17/2021CDE Solicits Comments on Technical Guidance for Clinical Trials of New...
  • 8/16/2021IQVIA Provides Snapshot and Outlook of County Level Healthcare Market
  • 8/16/2021PharmCube Reviews Development Trends of First-in-Class Drugs in China
  • 8/16/2021Review of Pharmaceutical Distribution Industry Performance in 2020
  • Page:201/802 Total number of articles:24054: [First][<<] [199] [200] [201] [202] [203] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group